Cargando…

Predictors for clinical effectiveness of baricitinib in rheumatoid arthritis patients in routine clinical practice: data from a Japanese multicenter registry

This study aimed to evaluate the short-term effectiveness and safety profiles of baricitinib and explore factors associated with improved short-term effectiveness in patients with rheumatoid arthritis (RA) in clinical settings. A total of 113 consecutive RA patients who had been treated with baricit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Nobunori, Asai, Shuji, Kobayakawa, Tomonori, Kaneko, Atsushi, Watanabe, Tatsuo, Kato, Takefumi, Nishiume, Tsuyoshi, Ishikawa, Hisato, Yoshioka, Yutaka, Kanayama, Yasuhide, Watanabe, Tsuyoshi, Hirano, Yuji, Hanabayashi, Masahiro, Yabe, Yuichiro, Yokota, Yutaka, Suzuki, Mochihito, Sobue, Yasumori, Terabe, Kenya, Ishiguro, Naoki, Kojima, Toshihisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736589/ https://www.ncbi.nlm.nih.gov/pubmed/33318522 http://dx.doi.org/10.1038/s41598-020-78925-8

Ejemplares similares

Inhibition of CD44 intracellular domain production suppresses bovine articular chondrocyte de-differentiation induced by excessive mechanical stress loading
por: Sobue, Yasumori, et al.
Publicado: (2019)

Changes in perioperative C-reactive protein levels in patients with rheumatoid arthritis undergoing total knee arthroplasty in the biologic era
por: Kishimoto, Kenji, et al.
Publicado: (2022)

A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and the effectiveness of abatacept in rheumatoid arthritis patients
por: Kida, Daihei, et al.
Publicado: (2020)

Relationship between rheumatoid arthritis and locomotive syndrome: validation of the 25-question Geriatric Locomotive Function Scale in patients with rheumatoid arthritis
por: Sobue, Yasumori, et al.
Publicado: (2019)

Hyaluronan promotes TRPV4-induced chondrogenesis in ATDC5 cells
por: Ogawa, Yoshikazu, et al.
Publicado: (2019)

Hyaluronan Oligosaccharides Induce MMP-1 and -3 via Transcriptional Activation of NF-κB and p38 MAPK in Rheumatoid Synovial Fibroblasts
por: Hanabayashi, Masahiro, et al.
Publicado: (2016)

Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity
por: Takahashi, Nobunori, et al.
Publicado: (2013)

Activation of transient receptor potential vanilloid 4 protects articular cartilage against inflammatory responses via CaMKK/AMPK/NF-κB signaling pathway
por: Hattori, Kyosuke, et al.
Publicado: (2021)

Hyaluronan suppresses enhanced cathepsin K expression via activation of NF-κB with mechanical stress loading in a human chondrocytic HCS-2/8 cells
por: Suzuki, Mochihito, et al.
Publicado: (2020)

Locomotive syndrome in rheumatoid arthritis patients during the COVID-19 pandemic
por: Sobue, Yasumori, et al.
Publicado: (2022)

Computed tomography evaluation of the periacetabular gap of a porous tantalum acetabular component
por: Asai, Shuji, et al.
Publicado: (2019)

Validation of grip strength as a measure of frailty in rheumatoid arthritis
por: Sobue, Yasumori, et al.
Publicado: (2022)

Predictors of denosumab efficacy in treating osteoporosis in patients with rheumatoid arthritis: a Japanese multicenter study
por: Hattori, Kyosuke, et al.
Publicado: (2019)

Hyaluronan Inhibits Tlr-4-Dependent RANKL Expression in Human Rheumatoid Arthritis Synovial Fibroblasts
por: Watanabe, Tatsuo, et al.
Publicado: (2016)

Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies
por: Hirabara, Shinya, et al.
Publicado: (2014)

Metabolic reprogramming in chondrocytes to promote mitochondrial respiration reduces downstream features of osteoarthritis
por: Ohashi, Yoshifumi, et al.
Publicado: (2021)

Soluble Siglec-9 suppresses arthritis in a collagen-induced arthritis mouse model and inhibits M1 activation of RAW264.7 macrophages
por: Matsumoto, Takuya, et al.
Publicado: (2016)

Prediction of progression of damage to articular cartilage 2 years after anterior cruciate ligament reconstruction: use of aggrecan and type II collagen biomarkers in a retrospective observational study
por: Sobue, Yasumori, et al.
Publicado: (2017)

Successful Perioperative Combination of High-Dose FVIII Therapy Followed by Emicizumab in a Patient with Hemophilia A with Inhibitors
por: Okamoto, Shuichi, et al.
Publicado: (2019)

Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19
por: Izumo, Takehiro, et al.
Publicado: (2021)

Effectiveness of Baricitinib in Refractory Seronegative Rheumatoid Arthritis and Uveitis: A Case Report
por: Kaneko, Yutaka, et al.
Publicado: (2022)

Pneumococcal polyarticular septic arthritis after a single infusion of infliximab in a rheumatoid arthritis patient: a case report
por: Hayashi, Masatoshi, et al.
Publicado: (2012)

New alternative in the treatment of rheumatoid arthritis: clinical utility of baricitinib
por: Kawalec, Paweł, et al.
Publicado: (2019)

Efficacy of the combination of baricitinib, remdesivir, and dexamethasone in hypoxic adults with COVID-19: A retrospective study
por: Yasuda, Yuto, et al.
Publicado: (2022)

Application of Baricitinib in Dermatology
por: Zhang, Jingya, et al.
Publicado: (2022)

BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis
por: Abe, Hiroyuki, et al.
Publicado: (2023)

Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis
por: Harigai, Masayoshi, et al.
Publicado: (2020)

Additional baricitinib loading dose improves clinical outcome in COVID-19
por: Hasan, Md Jahidul, et al.
Publicado: (2020)

The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19
por: Richardson, Peter J., et al.
Publicado: (2022)

Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
por: Cantini, Fabrizio, et al.
Publicado: (2020)

Baricitinib for the treatment of rheumatoid arthritis
por: Urits, Ivan, et al.
Publicado: (2020)

Baricitinib and primary biliary cholangitis
por: Gordon, Stuart C., et al.
Publicado: (2021)

Baricitinib for the Treatment of Alopecia Areata
por: Freitas, Egídio, et al.
Publicado: (2023)

Clinical characteristics of geriatric patients with non-specific chronic low back pain
por: Sakai, Yoshihito, et al.
Publicado: (2022)

Exposure to Maternal Immune Activation Causes Congenital Unfolded Protein Response Defects and Increases the Susceptibility to Postnatal Inflammatory Stimulation in Offspring
por: Shimizu, Yo, et al.
Publicado: (2021)

Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN study
por: van der Heijde, Désirée, et al.
Publicado: (2018)

Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis
por: Emery, Paul, et al.
Publicado: (2020)

A Fatal Case of Relapsing Pneumonia Caused by Legionella pneumophila in a Patient with Rheumatoid Arthritis After Two Injections of Adalimumab
por: Hayashi, Masatoshi, et al.
Publicado: (2013)

Baricitinib and the Risk of Incident Interstitial Lung Disease: A Descriptive Clinical Case Report from Clinical Trials
por: Salvarani, Carlo, et al.
Publicado: (2021)

15. Eosinophilic pneumonitis secondary to baricitinib
por: Yein, Khin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_49rj2oni129qnnpo3tum4s5v4t